Health
Lilly Wants Records of People Who Took Weight-Loss Knockoffs
- Company says it requested the information for safety reasons
- Compounding pharmacies say the products are legal and needed
Eli Lilly’s headquarters in Indianapolis, Indiana.
Photographer: AJ Mast/BloombergThis article is for subscribers only.
Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their medical records for safety reasons, a move that comes as it builds a case against businesses selling the compounded drugs.
Compounding pharmacies have used a legal provision that allows them to make knockoff versions of Lilly’s Zepbound and Mounjaro while they are in a shortage. While Lilly has raised questions about the quality of those products, and some state inspections have found worrisome practices, the pharmacies say they are following the law and helping Americans get medicines they need.